EMBRACE OF UNPROVEN COVID TREATMENT HINDERS DRUG TRIALS

被引：40

作者：

Mega, Emiliano Rodriguez

机构：

来源：

NATURE | 2020年 / 586卷 / 7830期

关键词：

SARS-CoV-2; Public health; Medical research; Health care; Government; Diseases;

D O I：

10.1038/d41586-020-02958-2

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Latin America's embrace of unproven COVID treatment hinders drug trials Unchecked ivermectin use in region is making it difficult to test anti-parasite drug's effectiveness against the coronavirus. Unchecked ivermectin use in the region is making it difficult to test the anti-parasite drug's effectiveness against the coronavirus.

引用

页码：481 / 482

页数：2

共 3 条

[1] The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro [J].